Larimar Therapeutics (LRMR) Other Non-Current Assets (2013 - 2026)

Larimar Therapeutics (LRMR) has reported Other Non-Current Assets for 14 consecutive years, with $480000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets fell 20.79% year-over-year to $480000.0; the trailing twelve-month figure through Jun 2026 stood at $480000.0 (down 20.79% YoY), and the FY2025 full-year result was $606000.0, changed 0.0% from the prior year.
• Other Non-Current Assets retreated to $480000.0 in Q2 2026 per LRMR's latest filing, from $606000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.3 million in Q1 2022 and bottomed at $480000.0 in Q2 2026.
• Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets changed 0.0% in 2022, then sank 54.74% in 2024.
• Over 5 years, Other Non-Current Assets stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then plunged by 54.74% to $606000.0 in 2024, then changed by 0.0% to $606000.0 in 2025, then dropped by 20.79% to $480000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $480000.0, $606000.0, and $606000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.